Study Evaluating Single Ascending Doses Of ILS-920


Phase 1 Results N/A

Summary of Purpose

This is a first-in-human study of ILS-920. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ILS-920 after administration of ascending single intravenous (IV) doses to healthy adult subjects.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 February 2010.

1 Feb 2009 10 Dec 2008 1 Jul 2009 1 Jul 2009 1 Feb 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available